Viewing StudyNCT00326339



Ignite Creation Date: 2024-05-05 @ 4:51 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00326339
Status: COMPLETED
Last Update Posted: 2009-04-20
First Post: 2006-05-12

Brief Title: Treatment of Arthritis With Syk Kinase Inhibition TASKI-1
Sponsor: Rigel Pharmaceuticals
Organization: Rigel Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Rheumatoid Arthritis
Keywords:
Name View
Syk Kinase View
R935788 View
Rheumatoid Arthritis View